3vnt: Revision history

20 March 2024

• curprev 11:4011:40, 20 March 2024‎ OCA talk contribs‎ 4,981 bytes −2,423‎ No edit summary

27 July 2022

• curprev 21:5421:54, 27 July 2022‎ OCA talk contribs‎ 7,404 bytes +120‎ No edit summary

11 August 2016

• curprev 23:0223:02, 11 August 2016‎ OCA talk contribs‎ 7,284 bytes +140‎ No edit summary

5 January 2015

• curprev 15:5115:51, 5 January 2015‎ OCA talk contribs‎ 7,144 bytes +3,186‎ No edit summary

7 August 2013

• curprev 21:5721:57, 7 August 2013‎ OCA talk contribs‎ 3,958 bytes +131‎ No edit summary

25 March 2013

• curprev 08:5308:53, 25 March 2013‎ OCA talk contribs‎ 3,827 bytes +2,501‎ No edit summary

11 April 2012

• curprev 09:5709:57, 11 April 2012‎ OCA talk contribs‎ 1,326 bytes +1,114‎ No edit summary

15 February 2012

• curprev 09:1509:15, 15 February 2012‎ OCA talk contribs‎ 212 bytes +24‎ No edit summary

25 January 2012

• curprev 09:0509:05, 25 January 2012‎ OCA talk contribs‎ m 188 bytes 0‎ Protected "3vnt" [edit=sysop:move=sysop]
• curprev 09:0509:05, 25 January 2012‎ OCA talk contribs‎ 188 bytes +188‎ New page: '''Unreleased structure''' The entry 3vnt is ON HOLD Authors: Oki, H. Description: Crystal Structure of the Kinase domain of Human VEGFR2 with a [1,3]thiazolo[5,4-b]pyridine derivative